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Abstract
Introduction: Rheumatoid arthritis (RA) is a chronic disease causing recurring inflammatory joint attacks. These
attacks are characterized by macrophage infiltration contributing to joint destruction. Studies have shown that RA
treatment efficacy is correlated to synovial macrophage number. The aim of this study was to experimentally
validate the use of in vivo superparamagnetic iron oxide nanoparticle (SPION) labeled macrophages to evaluate RA
treatment by MRI.
Methods: The evolution of macrophages was monitored with and without dexamethasone (Dexa) treatment in
rats. Two doses of 3 and 1 mg/kg Dexa were administered two and five days following induction of antigen
induced arthritis. SPIONs (7 mg Fe/rat) were injected intravenously and the knees were imaged in vivo on days 6, 10
and 13. The MR images were scored for three parameters: SPION signal intensity, SPION distribution pattern and
synovial oedema. Using 3D semi-automated software, the MR SPION signal was quantified. The efficacy of SPIONs
and gadolinium chelate (Gd), an MR contrast agent, in illustrating treatment effects were compared. Those results
were confirmed through histological measurements of number and area of macrophages and nanoparticle clusters
using CD68 immunostaining and Prussian blue staining respectively.
Results: Results show that the pattern and the intensity of SPION-labeled macrophages on MRI were altered by Dexa
treatment. While the Dexa group had a uniform elliptical line surrounding an oedema pocket, the untreated group
showed a diffused SPION distribution on day 6 post-induction. Dexa reduced the intensity of SPION signal 50-60% on
days 10 and 13 compared to controls (P = 0.00008 and 0.002 respectively). Similar results were found when the signal was
measured by the 3D tool. On day 13, the persisting low grade arthritis progression could not be demonstrated by Gd.
Analysis of knee samples by Prussian blue and CD68 immunostaining confirmed in vivo SPION uptake by macrophages.
Furthermore, CD68 immunostaining revealed that Dexa treatment significantly decreased the area and number of
synovial macrophages. Prussian blue quantification corresponded to the macrophage measurements and both were in
agreement with the MRI findings.
Conclusions: We have demonstrated the feasibility of MRI tracking of in vivo SPION-labeled macrophages to assess RA
treatment effects.
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Introduction
Rheumatoid arthritis (RA) is one of the most common in-
flammatory bone conditions with a rising prevalence due
to the increase in the life expectancy of the population.
Because of its chronic nature and bone destructive effects,
RA is associated with a high rate of disability and morbi-
dity among patients, substantially diminishing their quality
of life [1]. Currently, diagnosis of RA mainly depends on
clinical scoring, serum rheumatoid factor and identifica-
tion of erosive lesions on conventional radiographs. These
methods do not allow early intervention at a point when
permanent joint damage can be prevented. They also do
not address the complicated nature of the disease where
patients can show little or no signs of inflammation during
ongoing episodes of joint damage [2]. Thus new tech-
nology allowing early onset and precise assessment and
follow-up during and after treatment would be of great
value to RA management.
Magnetic resonance imaging (MRI) is an advanced and
sophisticated technology that is constantly evolving and
can be used for imaging inflammatory bone diseases [3]. It
is possible to detect joint effusion and synovial inflam-
mation as well as bone and cartilage changes when non-
contrast enhancement MRI is used. This is due to the fact
that tissues show natural contrast due to their relative T1
(longitudinal) and T2 (transverse) relaxation properties, as
protons in water and tissue are diamagnetic and therefore
have some effect on the local magnetic field. However,
contrast can be enhanced by the addition of agents that
speed up these relaxation processes or disturb the local
field. Traditional contrast agents such as gadolinium che-
late (Gd), which is paramagnetic, weakly attract the local
field causing mainly a reduction in T1 relaxation time by
interaction of the tissue protons with its unpaired elec-
trons. Therefore, a faster return to equilibrium of nearby
protons takes place causing a hyperintense signal on
T1-weighted images. The magnetic enhancement effects
of Gd are amplified during inflammatory arthritis where
the increase in vascular permeability induced by synovial
inflammation allows a deeper diffusion into the tissues.
While the use of conventional contrast agent has some
benefits over non-enhanced imaging, it remains non-
specific and does not provide cellular and molecular infor-
mation. Thus, a more specific synovial contrast than that
offered by non-enhanced and Gd-enhanced MRI would
significantly improve RA diagnosis.
Nanotechnology is a rapidly growing field with a wide
variety of applications, particularly in biomedicine. Among
those applications are magnetic resonance (MR) diagnos-
tic enhancement and molecular imaging using superpara-
magnetic iron oxide nanoparticles (SPION). These SPION
applications exploit the strong paramagnetic effect of the
nanoparticles in the presence of an external magnetic field
due to their iron oxide nanocrystal core [4]. Several
classifications of SPIONs exist that are based on the
hydrodynamic particle size, polymeric coating material
and their biomedical application. The classification most
widely used is that based on the hydrodynamic particle
size. Iron oxide nanoparticles with a mean hydrodyna-
mic diameter that is more than 50 nm are those most
widely used in clinical applications and are referred to as
SPIONs, whereas those with a hydrodynamic diameter of
less than 50 nm are known as ultra small superparamag-
netic iron oxide (USPIO) particles [5].
SPIONs are considered to be T2 contrast agents inter-
acting strongly with the local field causing a dephasing
effect and loss of signal in that field. This is accompanied
by a faster T2 relaxation time and causes the absence of
signal from surrounding protons soon after the excitation
pulse. Thus, the SPION MR signal is hypointense on both
T1- and T2-weighted images. New sequences are now
available that recover positive signal from such negative
contrast agents by exploiting ultra-short echo times (signal
acquired before the T2 decay) [6,7] or the off-resonance
effects due to the disturbed local field [8,9].
In addition to their magnetic properties, the spon-
taneous phagocytosis of SPIONs by cells of the reticuloen-
dothelial system [10] which are upregulated at the sites of
infection and inflammation [11,12] have allowed resear-
chers to track in vivo labeled cell populations in several
pathological conditions. The dynamics of SPION phago-
cytosis control their biodistribution, which in turn de-
pends on several physicochemical characteristics. Those
characteristics include the size of the iron oxide crystals,
the type of their polymeric coating, the hydrodynamic size
of the coated particles and their charge. These parameters
can be adjusted to modulate the plasma half-life of
SPIONs and thus modulate their biodistribution and their
uptake by monocytic cells, which in turn determines the
biomedical applications of each type of SPION.
The feasibility of using SPION technology to enhance
MR imaging of arthritis models is well documented
[13-25]. However, most of these are proof-of-principle
and validation studies of this tool to assess phagocytic
activity at one particular time point. Consequently, they
provide little or no information on the potential of the
methods for follow-up studies. It is currently not known
if SPION can be used for cell tracking during the pro-
gression of experimental arthritis nor the evaluation of
RA treatments effects in vivo.
The goal of the current investigation was to evaluate
in vivo SPION-labeled macrophages as a tool for deter-
mining RA treatment efficacy using MRI in antigen-
induced arthritis (AIA). To that end, the AIA rat model
was used and the effects of a glucocorticosteroid, dexa-
methasone (Dexa), on disease progression were compared
to untreated arthritic animals during a period of two
weeks. We determined the changes in signal from the
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synovium of the knee joint caused by SPION-labeled mac-
rophages via qualitative and quantitative measurements.
These MRI results were then verified using thorough
histological measurements of both SPIONs and macro-
phages, confirming the accuracy of our MRI findings. Our
data clearly demonstrate the validity of using SPION-
labeled macrophages to experimentally assess RA treat-
ments in a fast and non-invasive approach and suggest a
possible clinical application for the evaluation of RA in
patients.
Methods
Animals
Thirty-three female Lewis rats were obtained from Janvier
Laboratories (Cedex, France). The rats weighed between
150 and 175 g and were 6 to 8 weeks old on arrival. They
were housed in the animal facility at the University of
Geneva under pathogen-free conditions in standard cages
and were fed standard diet and water ad libitum. Animal
handling was in accordance with guidelines of the Swiss
Committee of Animal Experiments. The experimental
protocol was approved by the Animal Care Committee at
the University of Geneva (authorization number 1049/
3580/3).
Induction of antigen-induced arthritis
All experimental procedures, animal manipulation, and
MR scanning were done under isoflurane inhalation
anesthesia (Nicholas Piramal, London, UK) (1.5% O2 and
air with 2 to 3% isoflurane). Animals were immunized by
a subcutaneous injection of 120 μL emulsified solution of
500 μg methylated bovine serum albumin (mBSA) (Sigma
Aldrich, St Louis, MO, USA)/50 μL saline plus 50 μL
complete Freund’s adjuvant (CFA) (Difco Labs, Detroit,
MI, USA) divided between four sites (two on the back
between the shoulder joints and each front paw). The ani-
mals simultaneously received an intra-peritoneal injection
of 2 × 109 cells of heat-inactivated Bordetella pertussis
(B.P.) (Lee Labs, Grayson, GA, USA) as an additional ad-
juvant. One week after the initial immunization, the ani-
mals received two booster subcutaneous injections (one
near each hip joint) of 100 μL of the same mBSA/CFA
emulsion and an additional intra-peritoneal B.P. injection
was administered at the same concentration. Three weeks
after the first immunization, mono-arthritis was induced
in the right knee joint by an intra-articular injection of
500 μg mBSA in 50 μL saline, and the contra-lateral knee
joint received 50 μL of saline and served as an internal
control.
Dexamethasone treatment protocol and contrast agents
(SPION and gadolinium chelate) administration
For modulation of disease progression and macro-
phage behavior in the AIA model the following Dexa
(Mephameson-4, Mepha Pharma, Basel, Switzerland)
treatment regimen was used: 3 and 1 mg/kg Dexa was
administered by intra-peritoneal injection on days 2 and
5 post-AIA induction respectively, and the controls (un-
treated group, with AIA) received an injection of the
same volume of sterile saline via the same route.
Five h after the last Dexa injection, the animals received
a single injection of 7 mg Fe/rat SPIONs intravenously in
the tail vein. During each MR scanning session (starting
24 h after SPION injection) on day 6 and again on days 10
and 13 post-AIA induction 0.25 mmol Gd/rat (Gadoteric
acid commercially available as Dotarem®, Guerbet, Cedex,
France) was administered via an intravenous cannula
inserted intra-peritoneally and fixed in place by a single
suture to ensure identical animal position for the pre- and
post-Gd MR images. Post-Gd MR images were obtained
within 5 to 7 minutes after injection.
SPION production and characterizing techniques
The naked SPIONs were manufactured by an aqueous
co-precipitation method to obtain maghemite phase
(γ-Fe2O3) [26,27]. Briefly, 0.064 moles of Fe
II from FeCl2
powder and 0.128 moles of FeIII from FeCl3 powder
(molar ratio FeII:FeIII = 1:2) were mixed in 1.5 L of water
at room temperature with 120 ml of ammonia (NH4OH
at 28%). After 10 minutes of reaction the suspension of
magnetite (Fe3O4) was sedimented by applying a mag-
netic field gradient and washed three times with water
until the pH reached 7. The naked SPION were then
redispersed in 400 ml and oxidized with 160 ml of nitric
acid (HNO3 at 2 M) and 240 ml of ferric nitrate
(Fe(NO3)3 at 0.35 M) under reflux for 90 minutes. The
black suspension became brown and was sedimented ap-
plying a magnetic field gradient and washed with water.
The naked SPION of maghemite phase (γ-Fe2O3) was
then dialyzed against HNO3 10 mM for 3 days by chan-
ging the washing solution every 12 h. The suspension
was finally centrifuged at 3 × 104 G for 15 minutes and
only the supernatant was kept.
Surface modification of the naked SPION with poly
vinyl alcohol (PVA) was done following a protocol de-
scribed previously [27-29]. Briefly, ten volumes of naked
SPION were mixed with nine volumes of PVA (PVA-OH
3.85 with a molecular weight of 14,000 g/mol) solution at
100 mgPVA-OH/ml and one volume of vinyl alcohol/vinyl
amine co-polymer (A-PVA M12 with a molecular weight
of 80,000 to 140,000 g/mol) solution at 20 mgA-PVA/ml).
The product will be referred to as SPIONs in this work.
Naked SPIONs and SPIONs iron concentrations (in
mgFe/ml) were measured with an induced coupled plasma
atomic emission spectroscope (ICP-OES) after dissolution
in hydrochloric acid solution (HCl at 6 M) and as such
(without dissolution) using a magnetosusceptometer (MS3
from Bartington®, Oxon, England) [30]. Transmission
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electron microscopy micrographs of SPION samples were
acquired using samples diluted to 50 μgFe/ml to obtain the
crystallite core sizes (referred to as cores size in Table 1).
Number-weighted hydrodynamic diameters (referred to as
particle size in Table 1) with polydispersity index (PDI in
Table 1) of naked SPIONs and SPIONs were measured on
photon correlation spectroscopy apparatus (PCS) at 400
μgFe/ml. Zeta potentials of the two types of particles were
also measured on the ZetaPals PCS apparatus at 400 μgFe/
ml at pH of approximately 7 adjusted with sodium hydrox-
ide (NaOH at 0.1 M). The amount of PVA present on
SPIONs was calculated after thermogravimetric analysis
from 30 to 800°C (10°C/minute) under air (30 ml/minute).
The saturation magnetization was obtained from freeze-
dried powder of naked SPIONs using a superconducting
quantum interference device (SQUID) [27].
MR imaging protocol
MR in vivo imaging of rat knee joints employed a Siemens
Magnetom® Trio 3 T clinical scanner (Siemens AG,
Erlangen, Germany) using the standard 4-cm loop coil and
respiratory monitoring with a pressure pad. The contralat-
eral left knee was imaged simultaneously as an internal
control.
The protocol began with a standard low-resolution
localization sequence and the isotropic resolution three-
dimensional ultra-short echo time (UTE) double-echo MR
sequence fixed orthogonal and at the magnet center [7,31].
These were subsequently used to localize the correct plane
for the two-dimensional or thinner slab three-dimensional
images as well as for quantitative analysis. The protocol
took approximately 40 minutes and the parameters of the
sequences used were as follows: (1) a three-dimensional
T1-gradient echo (VIBE) was used to detect and visualize
SPIONs by signal loss (negative contrast). Additionally,
VIBE was also repeated after Gd administration through
the intra-peritoneal cannula and without changing the pos-
ition of the animal for visualization of synovial edema via
non-specific contrast-agent uptake. The parameters were:
reception time/echo time (TR/TE) 14.3/5.9 ms, flip angle
12°, fat suppression, isotropic resolution 0.31 mm, and field
of view (FOV) 100 mm, acquisition time 4 minutes 54 sec-
onds; (2) difference ultra-short echo-time imaging (dUTE)
was used for detection and quantification of iron oxide par-
ticles positive contrast. SPION detection by the dUTE se-
quence consisted of the acquisition and subtraction of two
echo times (ultrashort TE, and short TE(2)) leading to posi-
tive contrast from short T2* species and reduced signal
elsewhere. The parameters were: three-dimensional iso-
tropic matrix 448 and 80 mm FOV, giving 180 μm in all
three dimensions, 50,000 radial projections, UTE/TE(2)
0.07 ms/2.46 ms (for in-phase fat/water image), TR 9.6 ms
(in vivo 100 segments), flip angle 10°, acquisition time
16 minutes 54 seconds.
Qualitative scoring of MR images
Three different parameters were defined and qualitatively
scored to assess the evolution of AIA in the absence and
presence of arthritis treatment on MR images. These pa-
rameters depended on the behavior of SPIONs and Gd in
arthritic knees and included the following: the intensity and
diffuseness of SPIONs in the inflamed synovium as well as
the severity of synovial edema depicted by Gd infiltration.
A scoring system from 0 to 3 was devised where a score of
0 denoted the lowest score and 3 the highest for any of
these parameters (0 is absence of parameter). Blinded scor-
ing was carried out by an experienced radiologist.
SPION signal quantification using segmentation software
and dUTE
dUTE provides quantifiable SPION signal related to con-
centration [32]. Three-dimensional volume segmentation
exploiting the contrast and monotonic signal/concentra-
tion correlation of dUTE allows unknown heterogeneous
regions of iron oxide uptake to be assessed in disease
models after systemic injection (custom software, Paracel-
sus Medical University, Salzburg, Austria). The analysis
software allows simultaneous segmentation of the two
simultaneously acquired UTE and TE(2) images and the
positive contrast iron oxide image. The semi-automatic
threshold method selects regions of similar intensity with
a radius constraint around a user-defined point and this is
repeated for all the regions of SPIONs in three-dimen-
sions. A histogram of pixel intensities in the dUTE image
is obtained from which the mean intensity value and total
volume in pixels and mm3 are reported.
Histology sample preparation
Knee joints (both the femur and tibia) were isolated and
fixed in 4% phosphate-buffered formalin for 48 h. Two em-
bedding techniques were used to prepare the knee samples,
which required two different methods of sample prepa-
ration: (1) for paraffin-embedded sections the samples were
decalcified in 10% ethylenediaminetetraacetic acid (EDTA)
(AppliChem, Darmstadt, Germany) for a period of 8 weeks.
Samples were then embedded in paraffin and sectioned at
5 μm thickness; (2) For Technovit® 9100 New-embedded
sections (Heraeus Kulzer, Hanau, Germany) the samples
were dehydrated in increasing concentrations of ethanol
for 24 h prior to xylene for 12 h at room temperature (RT).
Samples were subjected to pre-infiltration before the
infiltration solution (see manufacturer’s instructions) was
added to the samples for a 48-h incubation period at 4°C.
A freshly prepared polymerization solution was used to
embed the knee samples that were then evacuated at
200 mbar for 5 minutes. The polymerization process took
place between −2 and −20°C and was completed within
24 h. The embedded samples were cut using a special car-
bide blade at 5 μm thickness. Subsequently, the mounted
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sections were covered by parafilm and pressed overnight
(ON) at 60°C.
Histological staining
Immunohistochemistry
Paraffin sections were de-paraffinized, washed and blocked
using peroxidase blocking buffer (Dako, Hamburg,
Germany) before they were incubated with the primary
antibody mouse rat CD68 antibody (ABD Serotec,
Oxford, UK) at 1:50 titre for 1 h at RT in a moist cham-
ber. After two washes, the slides were incubated with
the secondary antibody, either peroxidase goat anti-
mouse IgG (Dako) or fluorescein isothiocyanate (FITC)
goat anti-mouse IgG (Jackson, West Grove, PA, USA)
for 30 minutes at RT. After two washes, the slides were
developed for 1 minute at RT using the one step AEC
solution (Biogenex, Fremont, CA, USA). Slides were
washed using washing buffer (Dako) twice as well as
twice with water. Mayer’s hematoxylin (Sigma-Aldrich)
was used as counterstaining. Technovit sections were
deplastized using xylene, 2-methoxyethylacetate twice
for 20 minutes each at RT followed by acetone twice for
5 minutes. Slides were blocked for 60 minutes using 5%
normal horse serum (Linaris, Mannheim, Germany) and
1% BSA. Endogenous avidin and biotin activity were
also blocked using avidin and biotin blocking solutions
(Vector Lab, Burlingame, CA, USA) for 60 minutes each
consecutively. The slides were washed in PBS before
they were incubated with the primary antibody mouse
anti-rat CD68 antibody (ABD) overnight (ON) at 1:100
titre in a 2% normal horse serum and 1% BSA solution.
The following day, the slides were washed and endoge-
nous perioxidase activity was blocked using 0.2% H2O2
for 15 minutes before adding the secondary antibody
horse anti-mouse IgG (Linaris) for 60 minutes in 1% nor-
mal horse serum and 1% BSA. ABC solution (Vector) and
DAB (Sigma-Aldrich) were used to develop the slides
for 45 minutes and 5 minutes respectively. Finally, the
slides were washed and counterstained using Mayer’s
hematoxylin before mounting.
Prussian blue staining
Paraffin sections were de-paraffinized and rehydrated in
water. A working solution of equal parts of 20% HCl and
10% K4Fe(CN)6 was incubated with the slides at RT for
20 minutes. After three washes with water, slides were
counterstained using Nuclear Fast Red for 5 minutes. Fi-
nally, slides were washed, dehydrated and mounted. When
performed following immunostaining, the working solu-
tion used was diluted to a final concentration of 1% HCl
solution and 1% K4Fe(CN)6 and incubated with the slides
for 3 minutes with no counterstaining.
Technovit sections were deplastized using xylene, 2-
methoxyethylacetate twice for 20 minutes each at RT
followed by acetone twice for 5 minutes. The slides were
then pre-treated with 5% K4Fe(CN)6 for 5 minutes at 40°C.
Subsequently, they were stained using 5% K4Fe(CN)6/HCl
solution for 30 minutes at 40°C. After several washes, the
sections were counterstained using Nuclear Fast Red,
washed, dried and mounted.
Quantification of immuno- and Prussian-blue staining
For image analysis, the number and percentage area of
macrophages (CD68 immunostained cells depicted in
brown) and SPIONs (Prussian-blue-stained particles de-
picted in blue) were quantified using three different types
of software. Image J and Cell profiler were used to quantify
different macrophage measurements and Definiens Tissue
Studio 3® was used for SPION measurements. A semi-
automated color selection and quantification process was
used in the case of Image J and a fully automated batch
processing script based on predetermined selection criteria
was employed in case of Cell Profiler and Definiens Tissue
Studio 3® (Definiens AG, München, Germany).
Statistical analysis
Statistical evaluation was carried out using SPSS 21.0 for
Mac using one-way analysis of variance (ANOVA) and
the Dunnett T3 test. P-values <0.05 were considered sta-
tistically significant.
Results
SPION characterization
The physicochemical characteristics of naked SPIONs and
SPIONs are summarized in Table 1. The naked SPIONs
and SPIONs concentrations were 10 and 5 mgFe/ml re-
spectively. Crystallite core sizes measured by TEM were
approximately 7 nm, which result in superparamagnetic
properties confirmed by saturation magnetization of
54 emu/g and the absence of a hysteresis [33]. Moreover,
the PVA coating did not affect either the SPION core size
or the saturation magnetization. The hydrodynamic par-
ticle sizes corresponding to the aggregation state of the
nanoparticles in aqueous suspension showed a difference
between uncoated and coated SPIONs. When the SPIONs
were naked, their average hydrodynamic size was approxi-
mately 14 nm and 25 nm with PVA coating. The increase
of the hydrodynamic size was due to the adsorption of
PVA on the particle surface. This measurement demon-
strates the coating effect of PVA onto naked SPIONs. Zeta
potential shifted from 0 to +16 mV due to PVA and
amino-PVA coating providing a positive Zeta potential of
SPIONs at physiological pH. Finally, thermogravimetric
analysis confirmed the presence of PVA with the naked
SPIONs in the mass ratio PVA/Fe equal to 9, as expected.
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MR imaging
To determine the validity of tracking in vivo SPION-
labeled macrophages for the assessment of RA treatment
effects and monitoring disease fluctuation, arthritic rats
were treated twice with Dexa on days 2 and 5 post-AIA
induction. A low dose of Dexa was chosen to modulate
the course of arthritis without completely eradicating the
underlying pathology. One dose of SPIONs (7 mg Fe/
animal) was administered intravenously a few hours after
the second dose of Dexa. In vivo MR imaging of the joints
was conducted on days 6, 10 and 13 following AIA induc-
tion. In Figure 1, a representative series of MR images
showing the distribution and evolution of the SPION-
labeled macrophages in untreated and Dexa-treated
groups can be seen. Two three-dimensional movies sho-
wing the detailed structures of the arthritic joint from the
coronal and sagittal views with and without SPIONs can
be seen in Additional files 1 and 2.
Images from the VIBE sequence depict the location of
SPIONs, which cause a loss of MR signal and are seen as
dark spots. In the upper panel A (i-iii), an inhomogeneous
and diffused elliptical black line was found in the middle of
a pocket of edema anterior to the femur and superior to
the joint on day 6 (Figure 1A-i). This line gradually became
more uniform and defined with time (Figure 1A ii and iii).
The position of the line also became more peripheral in
comparison to the edema and its intensity also decreased
by day 13. This pattern was significantly different in the
Dexa-treated group (Figure 1A iv-vi). Dexa-treated animals
exhibited a distinct and uniform dark line as early as day 6,
one day following SPION injection (Figure 1A-iv), and its
intensity decreased quickly, almost disappearing by day 13
(Figure 1A v, vi). In comparison, VIBE post-Gd images
of the same animals acquired a few minutes post-
administration revealed a difference between the two
groups on day 6 post AIA (Figure 1B i, iv) but no marked
difference between the Dexa-treated and untreated groups
on days 10 and 13 (Figure 1B ii, iii and v, vi). Gd
highlighted synovial and extra articular edema (synovial
inflammation) on VIBE, which otherwise could not have
been visualized. The inability of Gd to demonstrate a dif-
ference between Dexa-treated animals and the control
group was more evident at a later disease-stage where the
Gd MR signal in the knee joint and adjacent tissues had
decreased to a similar level in both groups (Figure 1B iii, vi).
The rate of signal decrease was also comparable in both
cases. This result was expected, as the extent of tissue
infiltration and distribution of Gd is directly related to
that of synovial inflammation, which resolves sponta-
neously with time in the AIA model (data not shown). For
comparison, T1-weighted MR images without SPION
administration, pre- and post-Gd on day 3, 6 and 10 are
shown in Additional file 3.
Qualitative assessment of MR images
These findings were further corroborated via qualitative
scoring of two criteria, diffuseness and intensity of SPION
signal. Blinded scoring of diffuseness and intensity of
SPION signal were conducted using a scale ranging from
0 to 3 on VIBE MR images. A score of 3 indicated high
signal diffuseness and intensity (Figure 2A-i and C-i)
and a score of 1 indicated low diffuseness and intensity
(Figure 2A-ii and C-ii). A timeline of SPION signal plotted
on days 6, 10 and 13 showed significantly high diffuseness
of SPIONs in the untreated animals compared to their
Dexa-treated counterparts, which scored very low in com-
parison (Figure 2B). By day 10, diffuseness scores of the
untreated group dropped as low as the Dexa-treated
group and remained unchanged up to day 13. In contrast,
SPION intensity decreased more gradually over time yet
remained elevated at all time points in the controls,
whereas it decreased at a much higher rate with Dexa
treatment and almost disappeared by day 13 (Figure 2D).
This dissimilarity in SPION evolution resulted in a sig-
nificant difference between the two groups on days 10 and
13 by which Dexa administration and efficacy could be
clearly distinguished.
Synovial inflammation was also assessed using a simi-
lar qualitative scoring system; however, signal intensity
post-Gd administration on VIBE images was used in that
case (Figure 2E i,ii). Although some effect of Dexa treat-
ment on the volume of the synovial inflammation was
detected on day 6, no difference between the two groups
was found on days 10 and 13 (Figure 2F). In both cases,
Gd demonstrated a gradual decrease in signal at a simi-
lar rate in the absence and presence of treatment. It was
clear that Gd was influenced more by the disease state
than by Dexa treatment. The Gd signal quantification
was not only scaled to its signal intensity, but also to its
regression reflected in the reduction in edema volume.
Table 1 Naked SPION and SPION characterization
Particles Medium Concentration,
mgFe/ml
Cores size, nm Particle size
(PDI), nm
Zeta potential at
pH 7, mV
PVA/Fe ratio,
mgPVA/mgFe
Saturation
magnetization, EMU/g
Naked SPION HNO3 10 mM 10 7.2 ± 2.5 14 ± 2 (0.25) 0 ± 3 0 54
SPION HNO3 5 mM 5 7.2 ± 2.5 25 ± 3 (0.20) +16 ± 3 9 54
Core sizes: diameter of SPION measured by transmission electron microscopy (TEM) image analyses; particle size: hydrodynamic number-weighted diameter
measured by PCS and given with polydispersity index.
SPION, superparamagnetic iron oxide nanoparticles; PDI, polydispersity index.
+/- are standard error for the core size and +/SD for the rest the parameters (Particle size and Zeta potential).
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Quantification of SPION MR signal
The validation of the SPION intensity results was per-
formed using semi-automated software for three-dimen-
sional quantification of signal intensity. The measurements
were conducted on dUTE images, which provided a
positive SPION signal and a higher contrast with sur-
rounding tissues allowing for easier and more precise sig-
nal segmentation (Figure 3A,B) and were compared
between the groups (Figure 3). The signal intensity mea-
surements were also highly accurate as they were based
Figure 1 The evolution of superparamagnetic iron oxide nanoparticles (SPION)-labeled macrophages signal on magnetic resonance
(MR) images in the presence and absence of dexamethasone (Dexa). (A) T1-weighted images (negative contrast) of SPION-labeled macrophages
in the synovium during AIA. SPIONs were administered intravenously on day 5 post-AIA induction. Panel (i-iii) shows representative MR images from a
control (untreated) animal with AIA and panel (iv-vi) shows MR images of a Dexa-treated animal on days 6, 10 and 13 post-AIA induction respectively.
(B) T1-weighted images of SPION-labeled macrophages post-Gd administration of the same two animals shown in A. SPION signal is seen as a negative
contrast, and Gd signal is seen as a positive contrast and depicts synovial edema. Panel (i-iii) shows representative MR images from a control (untreated)
animal with AIA and panel (iv-vi) shows MR images of a Dexa-treated animal on days 6, 10 and 13 post-AIA induction respectively. White arrows, SPION
signal (dark); red arrows, quadriceps tendon to patella (dark u-shaped line); yellow arrows: femur and tibia; broken yellow arrow, inflamed synovium
(bright signal); broken orange line, edema pocket anterior to the femur. Similar results were seen in 13 untreated controls and 15 Dexa-treated animals.
AIA, antigen-induced arthritis; Gd, gadolinium chelate.
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Figure 2 Qualitative scoring of antigen-induced arthritis (AIA) stage using superparamagnetic iron oxide nanoparticles (SPION)-labeled
macrophage and gadolinium chelate (Gd) signal in the synovium on days 6, 10 and 13 post-induction in the presence and absence of
dexamethasone (Dexa). (A) T1-weighted MR images showing the diffuseness of the SPION signal in the synovium; MR image with diffuseness
(i) score of 3 and (ii) score of 0. (B) Line graph showing the blinded scores of diffuseness of the Dexa-treated and untreated groups.
(C) T1-weighted MR images showing the intensity of the SPION signal in the synovium; MR image with intensity (i) score of 3 and (ii) score of 0.
(D) Line graph showing the blinded scores of intensity parameter of the Dexa-treated and untreated groups. (E) Post-Gd T1-weighted MR images
showing synovial inflammation as a positive contrast; MR image with synovial inflammation (i) score of 3 and (ii) score of 0. (F) Line graph showing
the blinded scores of synovial inflammation of the Dexa-treated and untreated groups. All data points are mean ± standard error of mean. B and
D: n = 13 untreated controls and n = 15 Dexa-treated group, reduced to 6 and 8 on day 13. B: P=1x10−8 on day 6, D: P = 0.00008 on day 10 and
0.002 on day 13 compared to the untreated control group. F: n = 20 on day 3, n = 14 on day 13, divided between Dexa-treated and untreated.
P = 0.00126 on day 6 compared to the untreated controls. Red and yellow arrows indicate the SPION regions of interest where the scoring criteria
were assessed. MR, magnetic resonance.
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on both the three-dimensional volume of MR signal and
the pixel intensity on every slice. Using this method, a dif-
ference between the Dexa-treated and untreated groups
could be seen at all time points (Figure 3C).
Histochemical and immunohistochemical staining analysis
and quantification
The MRI data were verified using histochemical and
immunohistochemical staining of the knee joint. First,
in vivo SPION uptake by macrophages and their distribu-
tion in the knee joint were assessed. To this end, Prussian
blue staining was used to visualize SPION clusters and
CD68 immunostaining was used as a macrophage-specific
marker. Simultaneous and consecutive double-staining
using Prussian blue and CD68 immunostaining were per-
formed for co-localization of SPIONs with macrophages.
Complete SPION compartmentalization by macrophages
in the synovium was demonstrated by both methods,
where almost all nanoparticles were located inside CD68-
positive cells (Figure 4A,B and C). Conversely, a large
population of macrophages did not show SPION uptake
at a 7 mg Fe/ml dose. This is likely due to the SPION bio-
distribution, which shows a significant preference towards
liver and spleen accumulation (Additional file 4) [34,35].
We proceeded to characterize macrophage distribution
and number in the synovium using samples from the ani-
mals that were imaged during our longitudinal MR study.
Initially on day 6, macrophages in both the absence and
presence of Dexa had uniformly and densely infiltrated
the synovial tissue (Figure 5A,D). On day 10, a trend to-
wards localization into subgroups at the edge of the syno-
vium was observed in both groups; however, this pattern
was more distinguishable in the Dexa group accompanied
by a decrease in macrophage number (Figure 5B,E).
Finally by day 13, the Dexa-treated group exhibits a
unique pattern of macrophage distribution from the con-
trols (Figure 5C,F). In the Dexa-treated group, a thick,
well-defined band of macrophages was seen at the peri-
phery of the synovium, outlining the pocket of articular
edema. The location and shape of the macrophage band
coincided with the elliptical line of hypointense/hyperin-
tense signal seen on VIBE/dUTE MR images respectively.
Although macrophages in the untreated group showed
some localization around the edge of the synovial tissues,
their distribution pattern was not as distinguishable. The
analysis of the percentage of area of CD68-positive cells
around the region of interest showed 6 to 7% reduction in
the Dexa-treated group compared to the controls on days
10 (data not shown) and 13 (Figure 6A). The number of
CD68-positive cells was also diminished at both time
points (Figure 6B).
As a final confirmation for both the MR and immuno-
histochemistry measurements, the number and area of
SPION clusters were quantified. The analysis of Prussian
blue staining on day 13 (Figure 7A,B) was in line with
all our previous findings showing that Dexa treatment
Figure 3 Quantitative measurement of superparamagnetic iron oxide nanoparticles (SPION)-labeled macrophage signal in the
presence and absence of dexamethasone (Dexa) using three-dimensional semi-automated segmentation software with difference
ultra-short echo time (dUTE) magnetic resonance (MR) images. (A) T1-weighted MR images of SPION-labeled macrophages in the synovium
with varying hypointense signals (i) high (ii) low. (B) Corresponding dUTE MR images of the T1-weighted images seen in A with varying hyperintense
(positive contrast) signal in the synovium (i) high (ii) low, that were used for three-dimensional signal segmentation. (C) Box plot graph comparing the
SPION signal between the untreated and Dexa-treated groups using dUTE images. Data points ± standard error of the mean; n = 23, day 6; n = 22,
day 10; n = 14, day 13. P <0.05 compared to the untreated control group (day 6, P = 0.00035; day 10, P = 0.00004; day 13, P = 0.0033).
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significantly reduced the area and number of SPION clus-
ters in the synovium (Figure 7C,D).
Discussion
Inflammatory arthritis is a chronic autoimmune disease
causing recurrent episodes of joint inflammation with
varying degrees of severity. These inflammatory attacks
are associated with bone and cartilage erosion occurring
during the first 2 years of RA onset and as early as
4 months after the first attack [36-38]. Eventually the
structural damage affecting joint integrity leads to se-
rious long-term complications including collapsed joints
and permanent disability [1]. To date, commonly used
diagnostic tools are limited to physical examination and
scoring of certain clinical features of RA, radiographic
scoring of erosion and serum markers of matrix degra-
dation. Such techniques rely mostly on clinical signs and
symptoms associated with severe inflammation and ad-
vanced joint destruction preventing early detection and
intervention. Additionally, there are cases with asymp-
totic pathogenesis or with poor correlation between
clinical symptoms and joint destruction, which present
another compounding factor of RA adding to the diffi-
culty or failure in diagnosis and treatment of the disease
using those methods [2,39]. Recent clinical research has
shown the advantages of using non-enhanced MRI and
power Doppler ultrasound in diagnosing and assessing
RA in patients [40,41]. However, both of those methods
still provide no information for assessing treatment ef-
fects and disease evolution from a molecular and cellular
perspective. Without a tool providing in-depth informa-
tion and addressing all the limitations of the current
diagnostic methods, proper RA treatment with clear re-
mission will remain elusive.
In the present study we have assessed the effect of a
well-established RA treatment Dexa, using a novel im-
aging technology that combines innovative MR imaging
combined with nanoparticle technology, and validated
Figure 4 Photomicrographs of Prussian blue and CD68-immunostained sections confirming in vivo superparamagnetic iron oxide
nanoparticles (SPION) labeling of macrophages. (A) Double-stained photomicrographs of (i) Prussian-blue-stained SPIONs (ii) immunofluorescent-
stained macrophages using mouse anti-rat CD68 1ry antibody (as a marker of macrophages) and anti-mouse fluorescein isothiocyanate (FITC) second
antibody at 20 times magnification (iii) the overlay of the two previous images. (B, C) Photomicrographs of two separate examples of (i) Prussian blue
followed by (ii) CD68-immunostained sections at 40 times magnification. Sections were stained consecutively and micrographs of the same region of
interest were obtained.
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these findings with supportive histochemical and immu-
nohistochemical analyses of the imaged joint tissues.
Using rats, we conducted a longitudinal evaluation of AIA
progression in parallel with the cellular changes in the ab-
sence and presence of the treatment in the same animals
over a period of 13 days. The T1-weighted (VIBE) and
dUTE MR images of in vivo SPION-labeled macrophages
were analyzed both qualitatively and quantitatively and
the results were compared to those obtained from Gd-
enhanced T1-weighted images currently used clinically for
the detection of inflammation. A significant difference in
the MR signal of the SPION-labeled macrophages was
observed when Dexa was administered compared to the
untreated controls and those differences continued over
time. Immunohistochemistry and histochemistry showed
cellular co-localization between macrophages and the
SPIONs and we also quantified those two parameters. We
found that both the number of macrophages and SPION
clusters in the synovium significantly decreased with Dexa
treatment.
Figure 5 Photomicrographs of CD68-immunostained sections comparing the evolution of macrophages during antigen-induced
arthritis (AIA) in the presence and absence of dexamethasone (Dexa) treatment. Photomicrographs showing macrophages (20 times
magnification) on sections stained with a mouse anti-rat CD68 1ry antibody and a peroxidase goat anti-mouse IgG second antibody. The slides were
developed using one step AEC solution. Mayer’s hematoxylin was used as a counter staining. (A, B, C) Photomicrographs from untreated animals
(control group) on days 6, 10 and 13 post-AIA induction. (D, E, F) Photomicrographs from Dexa-treated animals on days 6, 10 and 13 post-AIA
induction. Red arrows indicate the edema pocket in the knee joint surrounded by inflamed synovial membrane with dense macrophage infiltration.
Figure 6 Quantification of the area and number of CD68-positive macrophages on day 13 post-antigen-induced arthritis (AIA) induction.
Photomicrographs of CD68-immunostained sections on day 13 post-AIA induction were scanned and the images were analyzed for the % area of
CD68-positive cells (A) and their number (B) using Image J and Tissue Studio® software, respectively. Four sections were quantified and averaged
per animal. Data points are mean ± standard error of the mean and n = 4 per group. *P = 0.023 (A) and 0.003 (B) compared to the untreated
control group.
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The central role of macrophages in pathogenesis of RA
is well established [11]. During inflammatory arthritis,
both resident and circulating macrophages are activated
and partake in the process of synovial infiltration and
hyperplasia [25]. Once in the synovium, macrophages pro-
duce a multitude of pro-inflammatory cytokines and
matrix degrading enzymes, which contribute to joint dam-
age. Hence, macrophages have been the focus of many
in vitro and in vivo studies and the target of RA treat-
ments. This developed into a clinical interest in synovial
macrophages where their number and response to treat-
ment was considered a reliable biomarker for RA. Gerlag
et al. and Haringman et al. assessed the response of pa-
tients to a group of RA treatments including prednisolone,
methotrexate and infliximab, via the measurement of the
number of CD68-positive cells in the intimal and sub-
lining regions of the synovium, using knee arthroscopy be-
fore and two weeks after treatment administration [42,43].
They found that the number of sub-lining CD68-positive
cells decreased in response to the treatment. Furthermore,
their number was directly correlated to the 28-joint count
disease activity score and standardized-response mean
score used to assess the disease activity in RA patients. In
contrast, using the same approach, ineffective treatment
did not affect the number of sub-lining macrophages [44].
They concluded that macrophages are a sensitive and reli-
able biomarker that should be used to assess patients’
disease activity before and after treatment, particularly in
clinical studies. The major disadvantage of their proposed
technique was the use of knee arthroscopy for this type of
assessment - an invasive and painful procedure.
Based on these findings we hypothesized that through
in vivo loading and tracking of macrophages using
SPIONs the effect of an RA treatment can be assessed
over a period of time using MRI as a non-invasive imaging
modality. Thus, we set up a treatment and imaging proto-
col to validate the use of SPIONs as an alternative method
to assess changes in the number of macrophages in vivo.
We chose a Dexa treatment regimen that would diminish
but not entirely eliminate AIA in order to have detectable
disease changes within the duration of the study. Our MR
imaging protocol was focused on the VIBE sequence be-
cause it is both SPION- and Gd-sensitive and therefore,
the effect of Dexa on both macrophages and synovial in-
flammation could be simultaneously compared. We were
able to show the feasibility of in vivo macrophage tracking
after SPION loading on MR images where a strong
SPION signal was seen in the synovium of both Dexa-
treated and control groups. However, this SPION signal
was significantly different in its distribution between the
two groups as early as 24 h after SPION injection.
Whereas the Dexa-treated animals had a distinct elliptical
line in the synovium, the untreated ones showed a diffuse
and inhomogeneous signal. The difference between the
groups continued throughout the study, where the Dexa
group showed a rapid decrease in signal intensity whereas
the untreated group showed some insignificant changes in
that parameter and much higher variability. After verifying
Figure 7 Distribution and quantification of Prussian blue stained superparamagnetic iron oxide nanoparticles (SPIONs) on day 13
post-antigen-induced arthritis (AIA) induction. Photomicrographs of Prussian-blue-stained sections showing an example of the distribution of
SPIONs (red arrows) in the synovium of untreated animal (A) versus a Dexa-treated animal (B) on day 13 post-AIA induction at 1.5 times magnification.
Quantification of the area (C) and number (D) of Prussian-blue-stained SPIONs on day 13 post-AIA induction. Photomicrographs of Prussian-blue-stained
sections were scanned and the images were analyzed for the area (C) and the number (D) of SPIONs using Tissue Studio® software. Four sections were
quantified and averaged per animal. Data points are mean ± standard error of the mean and n = 5 per group. *P = 0.005 (A) and 0.016 (B) compared to
the untreated control group.
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in vivo SPION labeling of macrophages using immuno-
staining and Prussian-blue staining, we concluded that
this technique offers a consistent and reproducible elegant
method to identify RA treatment and monitor cell beha-
vior during inflammatory arthritis.
During this process we have established two methods of
SPION signal quantification on MR images. The first
method was qualitative scoring by an expert radiologist,
which was based on identifying two parameters: SPION
diffuseness and intensity, followed by blinded grading of
their extent on MR images. The second method, a semi-
automated three-dimensional measurement of SPION in-
tensity and volume using dUTE-positive enhancement in
all the synovium, offers the following advantages. Three-
dimensional isotropic resolution allows volume analysis
that avoids sampling errors when quantifying representa-
tive regions. As with many biological processes the edema
can be an irregular shape and the SPION uptake can vary.
The quantitative method used here assessed the SPION
intensity as an integral over the whole synovium. An ad-
ditional advantage of dUTE is the suppression of all back-
ground signals providing contrast between SPION, bone
and muscle [32]. Thus, easier segmentation is therefore
possible and can be automated, avoiding false positives,
unlike the signal loss from bone and ligament structure
on T1-weighted MRI.
In contrast, the analysis of Gd MR images, the conven-
tionally used MR contrast agent, was less informative. Gd
highlighted only synovial inflammation, which is known
to decrease over time in the AIA model even in the ab-
sence of treatment. Therefore no definitive difference
could be seen between the two groups. Additionally, Gd
provided no information on the cellular responses to
Dexa, and the lack of this critical data can be misleading
in RA assessment, because it is the cellular interactions
that cause most of the damage to the affected joints even
in the absence of inflammatory signs such as edema. Fi-
nally, the Gd protocol required a systemic administration
during each MR imaging session, which is more compli-
cated, whereas SPIONs were injected once and tracked for
up to 10 days thereafter.
As further proof of the accuracy of our findings, we
quantified and correlated our MR results with histo-
logical data. Histological knee sections were immuno-
stained using CD68 antibody as a macrophage marker
and Prussian blue stained to visualize iron oxide nano-
particles. Both parameters assessed at different time
points were in line with the MR data and showed a par-
allel decrease of both the number of macrophages and
SPIONs in the joint. This evidence was the final verifica-
tion that indeed our MR tracking protocol of SPION-
labeled macrophages possessed the necessary sensitivity
to determine minute changes in the synovial macro-
phage population.
Nanoparticles are a well-established tool used to label
and track cells in vitro and in vivo in different disease
models [45]. Namely the mononuclear phagocyte system
(dendritic cells, monocytes and tissue macrophages), fi-
broblasts, synoviocytes, endothelial cells, tumor cells and
stem cells were shown to spontaneously internalize differ-
ent types of nanoparticles. In most studies, MRI was the
imaging modality of choice, exploiting the superpara-
magnetic properties of the iron oxide nanoparticles. Due
to the influx of macrophages into sites of inflammation,
MRI tracking of in vivo and in vitro labeled SPIONs has
become a popular method in studying conditions with
macrophage involvement such as myocardial infarction,
arthrosclerosis and arthritis. In cardiovascular research,
the use of SPIONs has reached clinical research, where
they were directly administered to patients to improve the
diagnosis of arterial stenosis and atherosclerotic plaques
[46-48]. In arthritis, previous studies have provided the
proof of principle for the potential of in vivo SPION-
labeled macrophages in depicting synovial hyperplasia
using different animal models [13,16,19-21,49]. The out-
come of this research was promising. It demonstrated the
feasibility of this technology and its advantages over non-
enhanced MRI and other standard contrast agents. Yet
little supporting evidence has been provided by those
studies on longitudinal cell-tracking and the use of the
technique to assess drug effects. Beckmann et al. [13]
evaluated the signal loss in the synovium due to SPION
injection over a period of 2 weeks and compared the
SPION signal in the absence and presence of Dexa. Al-
though the objectives of both the Beckmann study and
ours were similar, there are substantial differences in the
design and approach used. In the Beckmann study, the
animals received a new injection of SPION prior to each
imaging session and continued to receive a high dose of
Dexa every day, thus overlapping both SPION and treat-
ment protocols. As SPIONs remained in the synovium
between imaging sessions the results shown were a mix-
ture of old and newly injected SPIONs. Neither qualitative
nor quantitative assessment of the SPION signal was pro-
vided, only a short description of the images. Although
they were able to show a difference in the number of
macrophages between the two groups via histological as-
sessment, these differences were based on measurements
limited to parts of the synovium without showing any in-
formation on the effects of the SPIONs. More impor-
tantly, the repetitive SPION injection is neither a clinically
feasible approach nor does it allow the tracking of the
same macrophage population from the disease onset until
the end of the study. It was not shown whether this large
amount of SPIONs injected throughout the Beckmann
study might have had any side effects on the animal and/
or the evolution of the AIA model, which in turn could
affect the results. In contrast, our approach was more
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methodical and detailed, and the animals first received the
Dexa treatment followed by one dose of SPION injection.
The signal loss of the SPION-labeled macrophages in
the synovium was tracked over a period of time with
and without Dexa, creating a protocol that is clinically
applicable.
Conclusions
In this study we have demonstrated the accuracy and
robustness of MRI tracking of SPION-labeled macro-
phages during AIA through multiple MRI measure-
ments and using different techniques followed by a
detailed histological assessment of both the location
and the number of SPIONs and macrophages for both
the treated and untreated group. Our results present a
novel and clinically feasible protocol to assess experi-
mental arthritis and treatment effects that is simple,
non-invasive and highly reproducible, and that can en-
hance preclinical drug development.
Additional files
Additional file 1: A three-dimensional magnetic resonance (MR)
image stack showing the anatomy of the arthritic knee joint on
day 10 post-antigen-induced arthritis (AIA) induction from the
coronal and sagittal views acquired using a T1-weighted (VIBE) MRI
sequence.
Additional file 2: A three-dimensional magnetic resonance (MR)
image stack showing superparamagnetic iron oxide nanoparticles
(SPION) signal in relation to the anatomy of the arthritic knee joint
on day 10 post-antigen-induced arthritis (AIA) induction from the
coronal and sagittal views acquired using a T1-weighted (VIBE) MRI
sequence.
Additional file 3: The evolution of antigen-induced arthritis (AIA)
on magnetic resonance (MR) images in the presence and absence
of dexamethasone (Dexa) without superparamagnetic iron oxide
nanoparticles (SPION) administration. (A) T1-weighted MR images of
arthritic knee joints 3, 6 and 10 days post-AIA induction without any
contrast enhancement. Panel (i-iii) shows representative MR images from
a control (untreated) animal with AIA and panel (iv-vi) shows MR images
of a Dexa-treated animal at the same timepoints. (B) T1-weighted MR
images of arthritic knee joints 3, 6 and 10 days post-AIA induction
post-gadolinium chelate (Gd) administration; images are of the same two
animals shown in A. Gd signal is seen as a positive contrast and depicts
synovial edema. Panel (i-iii) shows representative MR images from a
control (untreated) animal with AIA and panel (iv-vi) shows MR images of
a Dexa-treated animal at the same time points. Red arrows, quadriceps
tendon to patella (dark u-shaped line); yellow arrows, patella, femur and
tibia; broken orange line, edema pocket anterior to the femur.
Additional file 4: Whole body T1-weighted magnetic resonance
(MR) images showing dose-dependent superparamagnetic iron
oxide nanoparticles (SPION) accumulation in the liver. T1-weighted
MR images of a whole body scan of Lewis rats 24 h after intravenous
SPION administration through the tail vein. SPION MR signal is seen as a
negative contrast. Animals received no SPION (A), 1 mg Fe/rat SPION
(B) and 4 mg Fe/rat SPION (C) respectively. Green line outlines the liver.
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